neutral
1 day agoThyrocare Technologies Allots 10.6 Crore Bonus Shares in Major Capital Expansion Move
Thyrocare Technologies announced the allotment of more than 10.6 crore bonus equity shares under a 2:1 issue, effectively tripling its paid-up share capital. The move is positioned as a value enhancing step for shareholders and reflects the company’s confidence in its financial stability and long term growth outlook. Thyrocare, a major player in India’s diagnostic and preventive healthcare segment, continues to maintain strong market presence supported by consistent demand and widespread testing services.
Tipranks• By Pooja Kumari
Explore:High Return Equity Mutual Fund
neutral
1 day agoThyrocare Technologies Allots 10.6 Crore Bonus Shares in Major Capital Expansion Move
Thyrocare Technologies announced the allotment of more than 10.6 crore bonus equity shares under a 2:1 issue, effectively tripling its paid-up share capital. The move is positioned as a value enhancing step for shareholders and reflects the company’s confidence in its financial stability and long term growth outlook. Thyrocare, a major player in India’s diagnostic and preventive healthcare segment, continues to maintain strong market presence supported by consistent demand and widespread testing services.
Tipranks• By Pooja Kumari
Explore:High Return Equity Mutual Fund
Recently
1 min read
73 words
Thyrocare tripled its paid-up capital through a major 2:1 bonus issue, reinforcing shareholder value and highlighting strong confidence in its healthcare growth trajectory.
Thyrocare Technologies announced the allotment of more than 10.6 crore bonus equity shares under a 2:1 issue, effectively tripling its paid-up share capital. The move is positioned as a value enhancing step for shareholders and reflects the company’s confidence in its financial stability and long term growth outlook. Thyrocare, a major player in India’s diagnostic and preventive healthcare segment, continues to maintain strong market presence supported by consistent demand and widespread testing services.
Thyrocare Technologies announced the allotment of more than 10.6 crore bonus equity shares under a 2:1 issue, effectively tripling its paid-up share capital. The move is positioned as a value enhancing step for shareholders and reflects the company’s confidence in its financial stability and long term growth outlook. Thyrocare, a major player in India’s diagnostic and preventive healthcare segment, continues to maintain strong market presence supported by consistent demand and widespread testing services.
Dec 1, 2025 • 09:15